Circulating biomarkers of response to sunitinib in gastroenteropancreatic neuroendocrine tumors: current data and clinical outlook
about
Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours.Pancreatic neuroendocrine tumors: approach to treatment with focus on sunitinibEverolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study.
P2860
Circulating biomarkers of response to sunitinib in gastroenteropancreatic neuroendocrine tumors: current data and clinical outlook
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Circulating biomarkers of resp ...... rent data and clinical outlook
@ast
Circulating biomarkers of resp ...... rent data and clinical outlook
@en
Circulating biomarkers of resp ...... rent data and clinical outlook
@nl
type
label
Circulating biomarkers of resp ...... rent data and clinical outlook
@ast
Circulating biomarkers of resp ...... rent data and clinical outlook
@en
Circulating biomarkers of resp ...... rent data and clinical outlook
@nl
prefLabel
Circulating biomarkers of resp ...... rent data and clinical outlook
@ast
Circulating biomarkers of resp ...... rent data and clinical outlook
@en
Circulating biomarkers of resp ...... rent data and clinical outlook
@nl
P2093
P2860
P1476
Circulating biomarkers of resp ...... rent data and clinical outlook
@en
P2093
P2860
P304
P356
10.2165/11632590-000000000-00000
P407
P577
2012-06-01T00:00:00Z